Literature DB >> 18487619

Scleroderma lung disease: "if you don't know where you are going, any road will take you there".

Charlie Strange, James R Seibold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487619     DOI: 10.1164/rccm.200802-304ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Utility of an open-source DICOM viewer software (OsiriX) to assess pulmonary fibrosis in systemic sclerosis: preliminary results.

Authors:  Alarico Ariani; Marina Carotti; Marwin Gutierrez; Elisabetta Bichisecchi; Walter Grassi; Gian Marco Giuseppetti; Fausto Salaffi
Journal:  Rheumatol Int       Date:  2013-08-15       Impact factor: 2.631

2.  A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients.

Authors:  H G Kim; D P Tashkin; P J Clements; G Li; M S Brown; R Elashoff; D W Gjertson; F Abtin; D A Lynch; D C Strollo; J G Goldin
Journal:  Clin Exp Rheumatol       Date:  2010-11-03       Impact factor: 4.473

3.  Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis.

Authors:  Kristine Phillips; Cathryn Byrne-Dugan; Eric Batterson; James R Seibold
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

4.  A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations.

Authors:  Hongtai Huang; Andrea Fava; Tara Guhr; Raffaello Cimbro; Antony Rosen; Francesco Boin; Hugh Ellis
Journal:  BMC Bioinformatics       Date:  2015-09-15       Impact factor: 3.169

5.  Circulating biomarkers of interstitial lung disease in systemic sclerosis.

Authors:  Harpreet K Lota; Elisabetta A Renzoni
Journal:  Int J Rheumatol       Date:  2012-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.